A report by Park et al suggests that low-level inflammation, specifically the activation of STAT3 via cytokines such as IL-6, is a requirement for development of hepatocellular carcinoma in mouse models with dietary or genetic obesity [30]. The gene discussed is STAT3; the disease is obesity due to melanocortin 4 receptor deficiency.